Marina Y. Kobernik

Marina Y. Kobernik

Auto-generated profile, based on publicly available information

Marina Y. Kobernik

Ye.A. Vagner Perm State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
VEV.D. Elkin
V.D. Elkin
EPE.V. Plotnikova
E.V. Plotnikova
MKM.Yu. Kobernik
M.Yu. Kobernik
IKI.D. Kuznetsov
I.D. Kuznetsov
TST.G. Sedova
T.G. Sedova
В статье представлены краткая характеристика ботулинического токсина, история его применения в медицинской практике, приведены основные показания к использованию в настоящее время. Особое внимание уделено коррекции косметических недостатков лица: гиперфункциональных мимических морщин, изменения овала лица. Описана технология производства ботулинического токсина. Подробно изложен механизм его действия, заключающийся в блокаде нейромышечных связей с развитием функциональной денервации мышц, также отражен процесс реиннервации, который развивается благодаря процессу спраутинга. Рассмотрены сравнительная характеристика и фармакологические особенности основных препаратов ботулотоксина типа A; приведены сведения о ботулотоксинах других серотипов. Описаны клиническая эффективность и переносимость препаратов ботулотоксинов, их биологическая активность, длительность действия, абсолютные и относительные противопоказания к применению, а также побочные реакции, включая ботулинофилию и формирование «маски ботокса». Отмечено, что разные препараты ботулотоксинов не взаимозаменяемы, а рекомендации по подбору доз не могут основываться на каком-то единственном перерасчетном коэффициенте. Уделено внимание образованию антител к ботулотоксинам, оказывающим влияние на выраженность и время действия препаратов. Показано, что результат ботулинотерапии в большой степени зависит от правильного выполнения техники инъекций: определения оптимальной дозы ботулотоксина и выбора мышц-мишеней. Данные литературы свидетельствуют об эффективности и безопасности применения ботулотоксина для коррекции инволюционных изменений лица.

23 May 2024 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
VEV. D. Elkin
V. D. Elkin
MKM. Yu. Kobernik
M. Yu. Kobernik
Objective. To give a comparative evaluation of the effectiveness and safety of acne treatment with systemic isotretinoin in monotherapy and together with combined oral contraceptives in women. Materials and methods. 65 women with severe papulo-pustular acne took part in the study. They were divided into two groups: group I consisted of 35 women who used systemic isotretinoin for acne in monotherapy; group II included 30 women who took systemic isotretinoin together with combined oral contraceptives. A comprehensive clinical and laboratory study was conducted. The study included a biochemical blood test to determine the lipid profile, liver transaminases, and hormonal homeostasis. The obtained results were analyzed using the methods of parametric and nonparametric statistics, the standard error (m) was used in the calculations, the level of statistical significance was noted at p 0.05. Results. In women treated for acne with systemic isotretinoin in monotherapy relief occurs in 4 weeks, and complete clinical recovery in 24 weeks after the beginning of therapy; when using systemic isotretinoin together with combined oral contraceptives, relief is determined in 2 weeks, and complete clinical recovery in 16 weeks of treatment. The main side effects of systemic isotretinoin were cheilitis, skin xerosis, retinoic dermatitis and telogen alopecia. Cheilitis was revealed in the majority of patients in both groups equally. Xerosis of the skin, retinoic dermatitis and telogen alopecia were more often observed in the 1st group. In women of the 1st group, the level of progesterone was significantly higher and the level of estradiol was lower than in women of the 2nd group. Conclusions. Systemic isotretinoin has shown high efficacy and safety in treatment for acne in women. Combined oral contraceptives normalize hormonal homeostasis, which helps to eliminate acne. When using systemic isotretinoin in combination with combined oral contraceptives, the main clinical effect occurs earlier, and adverse reactions are less frequent and less severe than in monotherapy. The combined use of systemic isotretinoin and combined oral contraceptives is the optimal method of acne treatment in women.

13 November 2024 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
MKMarina Y. Kobernik
Marina Y. Kobernik
VEVladimir D. Elkin
Vladimir D. Elkin
ZKZlata A. Krasilnikova
Zlata A. Krasilnikova
EPE. V. Plotnikova
E. V. Plotnikova
A 25-year-old woman came to consult a dermatovenerologist. The woman complained of a rapidly progressing painless lump on the right wing of her nose which developed after photo-rejuvenation treatment and the development of herpetic infection.in the place of a previous lipoma removed by radio wave surgery. The clinical picture was characterized by a solitary disc-shaped plaque, 2 cm in size, bluish-reddish-brownish in color, of a doughy consistency, significantly protruding above the skin surface, with clear borders and a smooth, shiny surface. There was a complex differential diagnostics, the final diagnosis was confirmed by the results of a histological examination, which revealed changes characteristic of lymphocytoma. The patient was treated with aminoquinoline preparations and topical glucocorticosteroids and rapid positive dynamics with complete regression of the skin pathological process was observed. A clinical case of skin lymphocytoma that occurred after several successive trigger factors such as lipoma formation and removal, photo rejuvenation procedures, and herpes infection is presented in the article. This is a fairly rare disease that does not have a pathognomonic clinical picture, so it is difficult to differentiate and diagnose it. The results of a pathomorphological examination are essential for the diagnosis. A positive effect with a complete regression of skin changes can quickly occur if treated correctly.

3 March 2026 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
TST. G. Sedova
T. G. Sedova
MKM. Yu. Kobernik
M. Yu. Kobernik
AZA. A. Zhukova
A. A. Zhukova
The COVID-19 pandemic has significantly influenced the course and clinical presentation of skin diseases. Literature data indicate frequent lesions of the mucous membranes, skin, and its adnexa following the novel coronavirus infection caused by SARS-CoV-2. The proportion of dermatoses associated with COVID-19 among infected patients reaches 20.4 %. Based on the time of their development, skin lesions associated with coronavirus infection, are classified as early (acute), observed, within 2 to 4 weeks. These include cutaneous angiitis, morbilliform, papulosquamous, and papulovesicular rashes, drug eruptions, urticaria, and factitial lesions. These dermatoses result from the direct effect of SARS-CoV-2, its toxins and metabolites on the skin and mucous membranes and/or from a concomitant drug-induced toxic-allergic reaction. Late (chronic) skin lesions develop from 1 month to 1 year after novel coronavirus infection or within 4 weeks after vaccination. Late skin diseases exacerbated by SARS-CoV-2 include papulosquamous dermatoses, post-COVID alopecia, allergic dermatoses, collagen vascular diseases, acneiform dermatoses, nail plate changes, erythema, bullous dermatoses, and psychogenic dermatoses. The pathological effect of SARS-CoV-2 in the late stages post-infection or post-vaccination is due to the affinity of certain keratinocyte structures for the virus. The virus enters the cell, stimulates T-lymphocyte activation, enhances T-helper cell proliferation, and hyperproduction of proinflammatory cytokines and antibodies. This leads to interleukins synthesis and hyperstimulation of tissue inflammation, impairing skin cell differentiation. A significant proportion of concomitant dermatoses and comorbid pathologies has been identified in patients with late skin lesions that developed within 1 year after SARS-CoV-2 or within 4 weeks after vaccination. Moderate to severe courses of post-COVID dermatoses and complicated clinical cases have been frequently reported. Most clinical observations have shown a predominance of widespread rashes, atypical localization, and atypical clinical presentations, with rare clinical variants being more common. Combinations of two and three dermatological nosologies in a single patient (multimorbidity) have been noted. Pathomorphosis (nosomorphosis) of papulosquamous and autoimmune skin diseases has been observed, manifesting as the evolution of one dermatosis into another.

24 December 2021 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
TSTatiana G. Sedova
Tatiana G. Sedova
VEVladimir D. Elkin
Vladimir D. Elkin
MKMarina Y. Kobernik
Marina Y. Kobernik
EBElena N. Borodina
Elena N. Borodina
Barraquer-Simons syndrome (SBS) belongs to the groupof lipodystrophy with complex etiology and pathophysiology and is characterized by progressive loss of subcutaneous fat, presumably related to autoimmune destruction of adipocytes. SBS is frequently associated with autoimmune disorders. Its first signs are found in childhood or puberty. It is characterized by gradual onset from the face with subsequent extension of the pathological process downwards without the involvement of the lower extremities. At the same time, there is a clear delimitation between the lipodystrophic and unaffected zones. The diagnosis of SBS is mainly based on clinical manifestations. Laboratory work-upis needed mostly to clarify any concomitant disorders. We describe a rare clinical case of the Barraquer-Simons syndrome in a 61-year-old woman, associated with chronic glomerulonephritis and C3-hypocomplementemia. The disease manifested at the age of 11 years with the fat loss in the face area. No familial history of SBS could be identified. Among the concomitant diseases, chronic glomerulonephritis and bilateral retinal angiopathy are of particular interest. The laboratory assessments showed proteinuria and microhematuria in the urine analysis and decreased C3 component of the complement in blood chemistry analysis. The skin pathology was represented by atrophy of the skin and soft tissues in the face, neck, upper limbs and trunk areas, with a clear delimitation in the upper third of the thighs, where normal subcutaneous fat was preserved. There was pronounced skin hypotrophy in the face area, with face disfiguration resembling a "dead man's face". To diagnose the Barraquer-Simons syndrome, in addition to the assessment of clinical manifestations, we used non-invasive diagnostic methods and the results of histological examination of a skin biopsy samples (the description of the specimen is given). Patients with SBS should be followed upwith the monitoring of their clinical and biochemical profiles and need an in-depth comprehensive examination by medical specialists to identify and treat their concomitant disorders.

12 February 2025 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
MKM. Yu. Kobernik
M. Yu. Kobernik
GSG K. Sadykova
G K. Sadykova
AKA. P. Kolenchenko
A. P. Kolenchenko
YNYu. S. Naumova
Yu. S. Naumova
Syphilis is a systemic venereal disease that causes skin, mucous membranes, internal organs and musculoskeletal system lesions, and damages the fetus in the womb. The fetus is infected in the 16th–20th weeks of pregnancy, mostly transplacentally. The outcomes of congenital syphilis are miscarriages, stillbirths, premature births, the birth of a child with active and latent course of syphilis, and the birth of a healthy child. A clinical case of untreated congenital syphilis with antenatal fetal asphyxia is presented. First of all, the attention is drawn to the aggravated obstetric anamnesis: the first and second pregnancies ended in intrauterine fetal asphyxia and therefore a non-developing pregnancy. In the 8th–9th weeks of the current pregnancy antibodies to Treponema pallidium were detected – IgG, M, titer 1:1280, and a consultation with a dermatovenereologist was recommended. However, during the entire pregnancy period, no dermatovenereological examination, tests or treatment measures were carried out. Concomitant trichomoniasis and acute respiratory viral infections in a mild form were revealed and sanitized twice. At 27 weeks of pregnancy, antenatal fetal asphyxia was determined by ultrasound examination. The autopsy of the fetus revealed intrauterine pneumonia, and the postmortem examination of the placenta – pronounced dystrophic changes specific to congenital syphilis. This case demonstrates that ignoring the dermatovenereological therapeutic and diagnostic measures which were required, contributed to the disease progression and resulted in the development of antenatal fetal asphyxia. Timely detection and correction of all existing changes are necessary for a favorable course of pregnancy.